Xu Y - Search Results

1

A circulating miRNA signature as a diagnostic biomarker for non-invasive early detection of breast cancer.

Zhang L, Xu Y, Jin X, Wang Z, Wu Y, Zhao D, Chen G, Li D, Wang X, Cao H, Xie Y, Liang Z. Zhang L, et al. Among authors: xu y. Breast Cancer Res Treat. 2015 Nov;154(2):423-34. doi: 10.1007/s10549-015-3591-0. Epub 2015 Oct 17. Breast Cancer Res Treat. 2015. PMID: 26476723

2

Associations between XPD polymorphisms and risk of breast cancer: a meta-analysis.

Jiang Z, Li C, Xu Y, Cai S, Wang X. Jiang Z, et al. Among authors: xu y. Breast Cancer Res Treat. 2010 Aug;123(1):203-12. doi: 10.1007/s10549-010-0751-0. Epub 2010 Jan 29. Breast Cancer Res Treat. 2010. PMID: 20111903

3

Identification and validation of a blood-based 18-gene expression signature in colorectal cancer.

Xu Y, Xu Q, Yang L, Ye X, Liu F, Wu F, Ni S, Tan C, Cai G, Meng X, Cai S, Du X. Xu Y, et al. Among authors: xu q. Clin Cancer Res. 2013 Jun 1;19(11):3039-49. doi: 10.1158/1078-0432.CCR-12-3851. Epub 2013 Mar 27. Clin Cancer Res. 2013. PMID: 23536436

4

Hyperplex-MRM: a hybrid multiple reaction monitoring method using mTRAQ/iTRAQ labeling for multiplex absolute quantification of human colorectal cancer biomarker.

Yin HR, Zhang L, Xie LQ, Huang LY, Xu Y, Cai SJ, Yang PY, Lu HJ. Yin HR, et al. Among authors: xu y. J Proteome Res. 2013 Sep 6;12(9):3912-9. doi: 10.1021/pr4005025. Epub 2013 Aug 16. J Proteome Res. 2013. PMID: 23909920

5

Nuclear-enriched abundant transcript 1 as a diagnostic and prognostic biomarker in colorectal cancer.

Wu Y, Yang L, Zhao J, Li C, Nie J, Liu F, Zhuo C, Zheng Y, Li B, Wang Z, Xu Y. Wu Y, et al. Among authors: xu y. Mol Cancer. 2015 Nov 9;14:191. doi: 10.1186/s12943-015-0455-5. Mol Cancer. 2015. PMID: 26552600 Free PMC article.

6

HER2 somatic mutations are associated with poor survival in HER2-negative breast cancers.

Wang T, Xu Y, Sheng S, Yuan H, Ouyang T, Li J, Wang T, Fan Z, Fan T, Lin B, Xie Y. Wang T, et al. Among authors: xu y. Cancer Sci. 2017 Apr;108(4):671-677. doi: 10.1111/cas.13182. Epub 2017 Apr 21. Cancer Sci. 2017. PMID: 28164408 Free PMC article.

7

HER2 Pro1170Ala polymorphism is associated with decreased survival rate in HER2-negative breast cancer.

Si P, Xu Y, Ouyang T, Li J, Wang T, Fan Z, Fan T, Lin B, Xie Y. Si P, et al. Among authors: xu y. Oncol Lett. 2017 May;13(5):3793-3798. doi: 10.3892/ol.2017.5866. Epub 2017 Mar 17. Oncol Lett. 2017. PMID: 28529593 Free PMC article.

8

Predictive value of BRCA1/2 mRNA expression for response to neoadjuvant chemotherapy in BRCA-negative breast cancers.

Xu Y, Ouyang T, Li J, Wang T, Fan Z, Fan T, Lin B, Xie Y. Xu Y, et al. Cancer Sci. 2018 Jan;109(1):166-173. doi: 10.1111/cas.13426. Epub 2017 Nov 10. Cancer Sci. 2018. PMID: 29047188 Free PMC article.

9

Identification and analysis of CHEK2 germline mutations in Chinese BRCA1/2-negative breast cancer patients.

Fan Z, Ouyang T, Li J, Wang T, Fan Z, Fan T, Lin B, Xu Y, Xie Y. Fan Z, et al. Among authors: xu y. Breast Cancer Res Treat. 2018 May;169(1):59-67. doi: 10.1007/s10549-018-4673-6. Epub 2018 Jan 22. Breast Cancer Res Treat. 2018. PMID: 29356917

10

KLHL22 activates amino-acid-dependent mTORC1 signalling to promote tumorigenesis and ageing.

Chen J, Ou Y, Yang Y, Li W, Xu Y, Xie Y, Liu Y. Chen J, et al. Among authors: xu y. Nature. 2018 May;557(7706):585-589. doi: 10.1038/s41586-018-0128-9. Epub 2018 May 16. Nature. 2018. PMID: 29769719

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

73,581 results

Search Page

Filters